Diagnosis of sexually transmissible infections is recognized as a key to both individual treatment and public health control, but in many contexts is unavailable or inaccessible, because the diagnostic methods can only be carried out in centralized, sophisticated laboratories. Recent technological advances have generated a variety of new diagnostic options, largely based around testing by the clinician at point-of-care, or self-testing at home. However despite having technical accuracy, the scale up of these technologies in primary health care services faces uncertain pathways and multiple barriers that can impede or even prevent implementation of promising strategies. Large-scale implementation of new point-of-care technology depends on a much wider range of features than simply biological accuracy, including the clinical, social and political context into which the technology is being introduced, and has implications for clinical service delivery, training, quality assurance, data management, supply chains, funding models and the patient experience. This talk will focus on point-of-care and home-based tests that have the potential to substantially increase diagnostic coverage for sexually transmissible infections and implementation research conducted to date to assess their scalability.